106 related articles for article (PubMed ID: 14571356)
21. [Risperidone use in child and adolescent psychiatric patients].
Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
[TBL] [Abstract][Full Text] [Related]
22. Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months.
Kelly DL; Conley RR; Love RC; Horn DS; Ushchak CM
J Child Adolesc Psychopharmacol; 1998; 8(3):151-9. PubMed ID: 9853689
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of weight gain induced by antipsychotic drugs.
Baptista T
J Clin Psychiatry; 2002 Mar; 63(3):245-6. PubMed ID: 11926725
[No Abstract] [Full Text] [Related]
24. Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.
Hellings JA; Zarcone JR; Crandall K; Wallace D; Schroeder SR
J Child Adolesc Psychopharmacol; 2001; 11(3):229-38. PubMed ID: 11642473
[TBL] [Abstract][Full Text] [Related]
25. Risperidone-induced hepatotoxicity in children and adolescents? A chart review study.
Szigethy E; Wiznitzer M; Branicky LA; Maxwell K; Findling RL
J Child Adolesc Psychopharmacol; 1999; 9(2):93-8. PubMed ID: 10461819
[TBL] [Abstract][Full Text] [Related]
26. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
Martin A; Scahill L; Anderson GM; Aman M; Arnold LE; McCracken J; McDougle CJ; Tierney E; Chuang S; Vitiello B
Am J Psychiatry; 2004 Jun; 161(6):1125-7. PubMed ID: 15169706
[TBL] [Abstract][Full Text] [Related]
27. Diet and the atypical neuroleptics.
Horrigan JP; Sikich L
J Am Acad Child Adolesc Psychiatry; 1998 Nov; 37(11):1126-7. PubMed ID: 9808916
[No Abstract] [Full Text] [Related]
28. Weight gain with risperidone.
Brecher M; Geller W
J Clin Psychopharmacol; 1997 Oct; 17(5):435-6. PubMed ID: 9316002
[No Abstract] [Full Text] [Related]
29. Risperidone-associated weight gain in children and adolescents: a retrospective chart review.
Martin A; Landau J; Leebens P; Ulizio K; Cicchetti D; Scahill L; Leckman JF
J Child Adolesc Psychopharmacol; 2000; 10(4):259-68. PubMed ID: 11191686
[TBL] [Abstract][Full Text] [Related]
30. Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder.
Scahill L; Jeon S; Boorin SJ; McDougle CJ; Aman MG; Dziura J; McCracken JT; Caprio S; Arnold LE; Nicol G; Deng Y; Challa SA; Vitiello B
J Am Acad Child Adolesc Psychiatry; 2016 May; 55(5):415-23. PubMed ID: 27126856
[TBL] [Abstract][Full Text] [Related]
31. Risperidone in anorexia nervosa.
Newman-Toker J
J Am Acad Child Adolesc Psychiatry; 2000 Aug; 39(8):941-2. PubMed ID: 10939220
[No Abstract] [Full Text] [Related]
32. Antipsychotic drugs and diabetes.
McIntyre RS
CMAJ; 2003 Mar; 168(6):673. PubMed ID: 12642417
[No Abstract] [Full Text] [Related]
33. Discontinuation of risperidone and reversibility of weight gain in children with disruptive behavior disorders.
Lindsay RL; Leone S; Aman MG
Clin Pediatr (Phila); 2004 Jun; 43(5):437-44. PubMed ID: 15208748
[TBL] [Abstract][Full Text] [Related]
34. Weight gain with risperidone among patients with mental retardation: effect of calorie restriction.
Cohen S; Glazewski R; Khan S; Khan A
J Clin Psychiatry; 2001 Feb; 62(2):114-6. PubMed ID: 11247096
[TBL] [Abstract][Full Text] [Related]
35. Case study: risperidone-induced hepatotoxicity in pediatric patients.
Kumra S; Herion D; Jacobsen LK; Briguglia C; Grothe D
J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):701-5. PubMed ID: 9136506
[TBL] [Abstract][Full Text] [Related]
36. [Idiopathic intracranial hypertension and obesity].
Naarden MT; Schuitemaker A; Braakman HM; van Doormaal TP; Porro GL; Straver JS
Ned Tijdschr Geneeskd; 2015; 159():A7980. PubMed ID: 25563779
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of risperidone in the treatment of three children with feeding disorders.
Berger-Gross P; Coletti DJ; Hirschkorn K; Terranova E; Simpser EF
J Child Adolesc Psychopharmacol; 2004; 14(4):621-7. PubMed ID: 15662156
[TBL] [Abstract][Full Text] [Related]
38. Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior.
Buitelaar JK
J Child Adolesc Psychopharmacol; 2000; 10(1):19-26. PubMed ID: 10755578
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotic-induced dyslipidemia treated with omega 3 fatty acid supplement in an 11-year-old psychotic child: a 1-year follow-up.
Pisano S; Gritti A; Catone G; Pascotto A
J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):139-41. PubMed ID: 23480323
[No Abstract] [Full Text] [Related]
40. Depot risperidone-induced adverse metabolic alterations in female rats.
Horska K; Ruda-Kucerova J; Karpisek M; Suchy P; Opatrilova R; Kotolova H
J Psychopharmacol; 2017 Apr; 31(4):487-499. PubMed ID: 28347258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
